Market closed
Pulse Biosciences/$PLSE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pulse Biosciences
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Ticker
$PLSE
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
75
ISIN
US74587B1017
Website
PLSE Metrics
BasicAdvanced
$1.1B
-
-$0.99
1.60
-
Price and volume
Market cap
$1.1B
Beta
1.6
52-week high
$25.00
52-week low
$6.66
Average daily volume
177K
Financial strength
Current ratio
15.581
Quick ratio
15.371
Long term debt to equity
6.054
Total debt to equity
7.241
Management effectiveness
Return on assets (TTM)
-43.61%
Return on equity (TTM)
-77.86%
Valuation
Price to book
9.26
Price to tangible book (TTM)
9.57
Price to free cash flow (TTM)
-24.663
Growth
Earnings per share change (TTM)
27.11%
3-year earnings per share growth (CAGR)
-22.88%
What the Analysts think about PLSE
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Pulse Biosciences stock.
PLSE Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PLSE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PLSE News
AllArticlesVideos
Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript
Seeking Alpha·5 days ago
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·3 weeks ago
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Pulse Biosciences stock?
Pulse Biosciences (PLSE) has a market cap of $1.1B as of May 16, 2025.
What is the P/E ratio for Pulse Biosciences stock?
The price to earnings (P/E) ratio for Pulse Biosciences (PLSE) stock is 0 as of May 16, 2025.
Does Pulse Biosciences stock pay dividends?
No, Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Pulse Biosciences dividend payment date?
Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders.
What is the beta indicator for Pulse Biosciences?
Pulse Biosciences (PLSE) has a beta rating of 1.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.